These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21861227

  • 1. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT, Wu YH, Lee MC, Wang L, Li CT, Chen CY, Lee H.
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [Abstract] [Full Text] [Related]

  • 5. [Expression of ERCC1 mRNA and its impact on the prognosis of patients with non-small cell lung cancer].
    Ma W, Li W, Gao M, Li XN.
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):371-4. PubMed ID: 21875468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I.
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T.
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [Abstract] [Full Text] [Related]

  • 11. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM, Luketich JD.
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [Abstract] [Full Text] [Related]

  • 12. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW, Wang YC, Cheng YW, Lee MC, Yeh KT, Wang L, Wang J, Chen CY, Lee H.
    Clin Cancer Res; 2011 Sep 15; 17(18):5991-9. PubMed ID: 21807637
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D, Setter C, Dahl O, Schild SE, Noack F.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):442-7. PubMed ID: 20950963
    [Abstract] [Full Text] [Related]

  • 14. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, Stocchi L, Mihaylova Z, Bellezza G, Del Sordo R, Daddi G, Crinò L, Tonato M.
    J Thorac Oncol; 2008 Apr 01; 3(4):365-73. PubMed ID: 18379354
    [Abstract] [Full Text] [Related]

  • 15. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH, Li J, Shi SB, Yu LC, Ge LP, Chen P.
    Jpn J Clin Oncol; 2010 Apr 01; 40(4):327-35. PubMed ID: 20056675
    [Abstract] [Full Text] [Related]

  • 16. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC.
    Int J Cancer; 2005 Jul 01; 115(4):545-55. PubMed ID: 15704107
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M, Tosi D, Palleschi A, Rosso L, Mendogni P, Santambrogio L.
    Eur Surg Res; 2008 Jul 01; 41(3):267-71. PubMed ID: 18594145
    [Abstract] [Full Text] [Related]

  • 18. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.
    Feng J, Zhang X, Zhu H, Wang X, Ni S, Huang J.
    Am J Clin Pathol; 2012 Aug 01; 138(2):230-5. PubMed ID: 22904134
    [Abstract] [Full Text] [Related]

  • 19. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT, Cheng YW, Chou MC, Sen-Lin T, Lai WW, Ho WL, Lee H.
    Clin Cancer Res; 2003 Sep 15; 9(11):4200-4. PubMed ID: 14519646
    [Abstract] [Full Text] [Related]

  • 20. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
    Bartolucci R, Wei J, Sanchez JJ, Perez-Roca L, Chaib I, Puma F, Farabi R, Mendez P, Roila F, Okamoto T, Taron M, Rosell R.
    Clin Lung Cancer; 2009 Jan 15; 10(1):47-52. PubMed ID: 19289372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.